CITIUS PHARMAC (Germany) Market Value
| 47N Stock | EUR 3.29 0.00 0.00% |
| Symbol | CITIUS |
CITIUS PHARMAC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CITIUS PHARMAC's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CITIUS PHARMAC.
| 10/23/2023 |
| 12/16/2024 |
If you would invest 0.00 in CITIUS PHARMAC on October 23, 2023 and sell it all today you would earn a total of 0.00 from holding CITIUS PHARMAC DL or generate 0.0% return on investment in CITIUS PHARMAC over 420 days. CITIUS PHARMAC is related to or competes with Nucletron Electronic, ARROW ELECTRONICS, Carsales, ELECTRONIC ARTS, SALESFORCE INC, Trade Desk, and FLOW TRADERS. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products tar... More
CITIUS PHARMAC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CITIUS PHARMAC's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CITIUS PHARMAC DL upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 53.43 | |||
| Value At Risk | (13.65) | |||
| Potential Upside | 9.69 |
CITIUS PHARMAC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CITIUS PHARMAC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CITIUS PHARMAC's standard deviation. In reality, there are many statistical measures that can use CITIUS PHARMAC historical prices to predict the future CITIUS PHARMAC's volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (1.57) | |||
| Total Risk Alpha | (2.53) | |||
| Treynor Ratio | (22.99) |
CITIUS PHARMAC DL Backtested Returns
CITIUS PHARMAC DL secures Sharpe Ratio (or Efficiency) of -0.19, which signifies that the company had a -0.19% return per unit of volatility over the last 3 months. CITIUS PHARMAC DL exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CITIUS PHARMAC's risk adjusted performance of (0.14), and Mean Deviation of 4.81 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0681, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CITIUS PHARMAC's returns are expected to increase less than the market. However, during the bear market, the loss of holding CITIUS PHARMAC is expected to be smaller as well. At this point, CITIUS PHARMAC DL has a negative expected return of -1.49%. Please make sure to confirm CITIUS PHARMAC's maximum drawdown, potential upside, and the relationship between the jensen alpha and value at risk , to decide if CITIUS PHARMAC DL performance from the past will be repeated in the future.
Auto-correlation | 0.00 |
No correlation between past and present
CITIUS PHARMAC DL has no correlation between past and present. Overlapping area represents the amount of predictability between CITIUS PHARMAC time series from 23rd of October 2023 to 20th of May 2024 and 20th of May 2024 to 16th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CITIUS PHARMAC DL price movement. The serial correlation of 0.0 indicates that just 0.0% of current CITIUS PHARMAC price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.36 | |
| Residual Average | 0.0 | |
| Price Variance | 22.53 |
CITIUS PHARMAC DL lagged returns against current returns
Autocorrelation, which is CITIUS PHARMAC stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CITIUS PHARMAC's stock expected returns. We can calculate the autocorrelation of CITIUS PHARMAC returns to help us make a trade decision. For example, suppose you find that CITIUS PHARMAC has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CITIUS PHARMAC regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CITIUS PHARMAC stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CITIUS PHARMAC stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CITIUS PHARMAC stock over time.
Current vs Lagged Prices |
| Timeline |
CITIUS PHARMAC Lagged Returns
When evaluating CITIUS PHARMAC's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CITIUS PHARMAC stock have on its future price. CITIUS PHARMAC autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CITIUS PHARMAC autocorrelation shows the relationship between CITIUS PHARMAC stock current value and its past values and can show if there is a momentum factor associated with investing in CITIUS PHARMAC DL.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in CITIUS Stock
CITIUS PHARMAC financial ratios help investors to determine whether CITIUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CITIUS with respect to the benefits of owning CITIUS PHARMAC security.